Go back to News
NEWS
GA_P advises Atrys Health on its entry into the Continuous Market
4 February, 2022
GA_P advises Atrys Health on its entry into the Continuous Market
Gómez-Acebo & Pombo has advised Atrys Health on its entry into the Continuous Market and its shares will start trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges next Monday, February 7. Atrys makes the leap to the Continuous Market with the aim of incorporating international equity funds as shareholders.
Atrys is currently listed on the BME Growth with a market capitalization of 600 million euros. Atrys is a global company that provides diagnostic services and precision medical treatment, pioneer in telemedicine and state-of-the-art radiotherapy. In terms of revenue, its turnover has grown from €4.5 million in 2016 to a proforma turnover of over €85 million in the first half of 2021 alone. And in that same period of just 6 years, it has grown from a team of 44 professionals to more than 2,000 today.
The GA_P team has been led by Guillermo Guerra, Corporate partner, and integrated by Jacobo Palanca and Irene Carreño Uría, Corporate associates, and Irene Medina, Banking associate.
Gómez-Acebo & Pombo has advised Atrys Health on its entry into the Continuous Market and its shares will start trading on the Madrid, Barcelona, Bilbao and Valencia Stock Exchanges next Monday, February 7. Atrys makes the leap to the Continuous Market with the aim of incorporating international equity funds as shareholders.
Atrys is currently listed on the BME Growth with a market capitalization of 600 million euros. Atrys is a global company that provides diagnostic services and precision medical treatment, pioneer in telemedicine and state-of-the-art radiotherapy. In terms of revenue, its turnover has grown from €4.5 million in 2016 to a proforma turnover of over €85 million in the first half of 2021 alone. And in that same period of just 6 years, it has grown from a team of 44 professionals to more than 2,000 today.
The GA_P team has been led by Guillermo Guerra, Corporate partner, and integrated by Jacobo Palanca and Irene Carreño Uría, Corporate associates, and Irene Medina, Banking associate.
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
20 May, 2025 
PUBLICATION
2 days ago
Invalidity of agreements concluded by director in breach of duty of loyalty
In Judgment no. 142/2025 of 11 April, the Madrid Provincial Court (Twenty-Eighth Chamber) addressed two issues relating to the bringing of actions for declaration of invalidity of two sale and purchase agreements concluded by a company director in breach of his duty of loyalty. On the one hand, and in view of the specific circumstances, it ruled on whether the company could formally assume the role of claimant in the dispute. On the other hand, it ruled on the importance of the fact that the disputed transactions were beneficial to the company concerned and on the possibility of a ‘tacit’ dispensation.
2 days ago 
PUBLICATION
15 Jul, 2025
A good transposition of the Women on Boards Directive
Ireland has incorporated the mandatory presence of 40% of female non-executive directors on the boards of listed companies as of 30 June 2026, by amending the Companies Act 2014. Unlike the legislation in Spain, the percentage has been limited to this class of directors.
15 Jul, 2025
PUBLICATION
06 Mar, 2025
Calling of meeting of shareholders, abuse of rights, resistance test
Once again: despite compliance with the formal requirements of a calling of meeting of shareholders, company resolutions may be unenforceable if there is an abuse of rights in said call
06 Mar, 2025
PUBLICATION
04 Mar, 2025
Rules to determine directors' remuneration: a case where Article 217(4) of the Companies Act applies
The Supreme Court applies the rules set out in Article 217(4) of the Companies Act to reach a decision concerning the contest of a board resolution that determined the remuneration of a company director.
04 Mar, 2025
PUBLICATION
27 Feb, 2025
An end to rules on racial, gender and LGTBQ+ diversity on Nasdaq-listed company boards
In Alliance for Fair Board Recruitment; NCPPR v. SEC, the U.S. Court of Appeals vacates, by a one-vote margin, the Securities & Exchange Commission’s approval in 2021 of Nasdaq’s rules on board diversity for companies listed on its exchange.
27 Feb, 2025
PUBLICATION
11 Feb, 2025
The concept of transferable securities and the exclusion of municipalities as qualified investors for the purposes of prospectus publications: CJEU judgment of 9 January 2025
In this judgment, the CJEU considers that shares whose transfer is subject to approval by the board of directors can be considered transferable securities for the purposes of the European prospectus legislation and MiFID.
11 Feb, 2025
PUBLICATION
10 Sep, 2024
Mandatory presence of female directors in listed companies and other public interest entities
10 Sep, 2024
PUBLICATION
21 Mar, 2024
Adoption of the Directive on empowering consumers for the green transition
The Directive on empowering consumers for the green transition imposes on producers and sellers of goods a number of obligations aimed at protecting consumers from misleading environmental claims (‘greenwashing’), helping consumers and users make more sustainable choices and increasing confidence in ecological information and labels.
21 Mar, 2024
PUBLICATION
18 Oct, 2021
Inside Information and Quarterly Financial Statements: CNMV Communication of 13 October 2021
The CNMV notes in this communication that, although there are no closed periods in respect of the voluntary publication by issuers of the quarterly financial report, this report may contain inside information, in which case the Market Abuse Regulation applies
18 Oct, 2021